➡ Français
➡ Português
➡ Español
![[Valid RSS]](images/icons/valid-rss-rogers.png "Validate my RSS feed"){kind=icon}
 | Database - (CIANE) |
Description of this bibliographical database (CIANE website) | |
|
https://ciane.net/id=671 | ➡ Modify this record   Hard |
|
Bibliographical entry (without author) : | Routine CMV screening during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 114(1):3-11. |
|
Author(s) : | Collinet P, Subtil D, Houfflin-Debarge V, Kacet N, Dewilde A, Puech F. |
|
Year of publication : | 2004 |
|
URL(s) : | |
|
Résumé (français) : |
|
|
Abstract (English) : | Cytomegalovirus (CMV) screening during pregnancy has been widely discussed for several years, but still no consensus has been agreed. With a number of live births of 750,000 per year in France, we would expect 7500 infected infants at birth per year (rate of congenital infection of 1%). Among infected infants at birth, the number of severely infected foetuses would be approximately 75, the number of infants with severe sequelae would be 480, 675 approximately would present with hearing loss and the number of asymptomatic infants would be 6270. Five different preventive methods for congenital CMV infection are possible: (1) Routine CMV screening at the beginning of pregnancy for primary prevention. (2) Secondary prevention by antenatal diagnosis of congenital CMV infection complications. (3) Tertiary prevention by serological testing during pregnancy. (4) Tertiary prevention by serological screening at birth. (5) Tertiary prevention: Hearing loss screening at birth. The aims of this review are to define the advantages and disadvantages of these different methods of CMV screening during pregnancy and to determine if the current available information would make systematic testing acceptable. |
|
Sumário (português) : |
|
|
Resumen (español) : |
|
|
Comments : | |
|
Argument (français) : |
|
|
Argument (English): | |
|
Argumento (português): |
|
|
Argumento (español): |
|
|
Keywords : | ➡ infections ; evidence-based medicine/midwifery ; prevention ; screening |
Author of this record : | Cécile Loup — 19 Apr 2004 |
| Discussion (display only in English) | ||
|---|---|---|
| [Hide guidelines] ➡ Discussion guidelines 1) Comments aim at clarifying the content of the publication or suggesting links for a better comprehension of its topic 2) All comments are public and opinions expressed belong to their authors 3) Avoid casual talk and personal stories 4) Any off-topic comment or containing inappropriate statements will be deleted without notice | ||
New expert query --- New simple query
Creating new record --- Importing records
User management --- Dump database --- Contact
This database created by Alliance francophone pour l'accouchement respecté (AFAR) is managed
by Collectif interassociatif autour de la naissance (CIANE, https://ciane.net).
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) contributing to this database if you have a minimum training in documentation
(2) or financially supporting CIANE (see below)
(3) or joining any society affiliated with CIANE.
➡ Sign in or create an account to follow changes or become an editor.
➡ Contact bibli(arobase)ciane.net for more information.
| Donating to CIANE (click “Faire un don”) will help us to maintain and develop sites and public databases towards the support of parents and caregivers’ informed decisions with respect to childbirth |